{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:00:52Z","timestamp":1792526452815,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijcha.2025.101841","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:57:52Z","timestamp":1762599472000},"page":"101841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pericarditis at the crossroads: Unlocking the next wave of therapies"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5722-0245","authenticated-orcid":false,"given":"Massimo","family":"Imazio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Venturelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Tomat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Savonitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Stolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Collini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2025.101841_b0005","doi-asserted-by":"crossref","unstructured":"Schulz-Menger J, Collini V, Gr\u00f6schel J, Adler Y, Brucato A, Christian V, Ferreira VM, Gandjbakhch E, Heidecker B, Kerneis M, Klein AL, Klingel K, Lazaros G, Lorusso R, Nesukay EG, Rahimi K, Risti\u0107 AD, Rucinski M, Sade LE, Schaubroeck H, Semb AG, Sinagra G, Thune JJ, Imazio M; ESC Scientific Document Group. 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur. Heart J. 2025 Aug 29:ehaf192. doi: 10.1093\/eurheartj\/ehaf192. Epub ahead of print. PMID: 40878297.","DOI":"10.1093\/eurheartj\/ehaf192"},{"issue":"19","key":"10.1016\/j.ijcha.2025.101841_b0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021685","article-title":"Emerging therapies for recurrent pericarditis: Interleukin\u20131 inhibitors","volume":"10","author":"La Presti","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"10.1016\/j.ijcha.2025.101841_b0015","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.ebiom.2015.10.009","article-title":"Tuberculous pericarditis: A complex puzzle to put together","volume":"2","author":"Lazaros","year":"2015","journal-title":"EBioMedicine"},{"issue":"16","key":"10.1016\/j.ijcha.2025.101841_b0020","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"I.C.A.P. Investigators A randomized trial of colchicine for acute pericarditis","volume":"369","author":"Imazio","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ijcha.2025.101841_b0025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"CORP (COlchicine for Recurrent Pericarditis) Investigators. Colchicine for recurrent pericarditis (CORP): a randomized trial","volume":"155","author":"Imazio","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"9936","key":"10.1016\/j.ijcha.2025.101841_b0030","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): A multicentre, double-blind, placebo-controlled, randomised trial","volume":"383","author":"Imazio","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ijcha.2025.101841_b0035","article-title":"Rilonacept and anakinra in recurrent pericarditis: A systematic review and meta\u2013analysis","volume":"14","author":"Affas","year":"2022","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.ijcha.2025.101841_b0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCULATIONAHA.120.051156","article-title":"Incessant pericarditis as a risk factor for complicated pericarditis and hospital admission","volume":"143","author":"Imazio","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2025.101841_b0045","doi-asserted-by":"crossref","unstructured":"M. Imazio, G. Lazaros, M. Gattorno, M. LeWinter, A. Abbate, A. Brucato, A. Klein, Anti-interleukin-1 agents for pericarditis: A primer for cardiologists. Eur. Heart J. 43(31) (2022 Aug 14) 2946\u20132957. Doi: 10.1093\/eurheartj\/ehab452. PMID: PMCID: PMC9375710.","DOI":"10.1093\/eurheartj\/ehab452"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101841_b0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijcard.2008.05.020","article-title":"Antinuclear antibodies in recurrent idiopathic pericarditis: Prevalence and clinical significance","volume":"136","author":"Imazio","year":"2009","journal-title":"Int. J. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcha.2025.101841_b0055","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/hrt.2009.187138","article-title":"Anti-heart and anti-intercalated disk autoantibodies: Evidence for autoimmunity in idiopathic recurrent acute pericarditis","volume":"96","author":"Caforio","year":"2010","journal-title":"Heart"},{"issue":"18","key":"10.1016\/j.ijcha.2025.101841_b0060","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2016.15826","article-title":"Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: The AIRTRIP randomized clinical trial","volume":"316","author":"Brucato","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ijcha.2025.101841_b0065","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/2047487319879534","article-title":"Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study","volume":"27","author":"Imazio","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101841_b0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa2027892","article-title":"RHAPSODY investigators. Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis","volume":"384","author":"Klein","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101841_b0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jacc.2023.04.046","article-title":"Treatment of idiopathic recurrent pericarditis with goflikicept: Phase II\/III study results","volume":"82","author":"Myachikova","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcha.2025.101841_b0080","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/CIRCULATIONAHA.107.761064","article-title":"Corticosteroids for recurrent pericarditis: High versus low doses: A nonrandomized observation","volume":"118","author":"Imazio","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcha.2025.101841_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/acr2.11776","article-title":"Duration of disease and long-term outcomes in patients with difficult-to-treat recurrent pericarditis: A chronic condition treated with nonsteroidal anti-inflammatory drugs, colchicine, corticosteroids, and anti-interleukin-1 agents","volume":"7","author":"Ceriani","year":"2025","journal-title":"ACR Open Rheumatol."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101841_b0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10741-012-9328-9","article-title":"Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis","volume":"18","author":"Imazio","year":"2013","journal-title":"Heart Fail. Rev."},{"issue":"6","key":"10.1016\/j.ijcha.2025.101841_b0095","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2459\/JCM.0000000000001618","article-title":"Medical therapy of pericarditis: Tips and tricks for clinical practice","volume":"25","author":"Imazio","year":"2024","journal-title":"J. Cardiovasc. Med. (Hagerstown)."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101841_b0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2459\/JCM.0000000000001684","article-title":"Update on the diagnosis and treatment of pericardial diseases: A position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseases","volume":"26","author":"Imazio","year":"2025","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101841_b0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijcard.2011.01.027","article-title":"Azathioprine in isolated recurrent pericarditis: a single centre experience","volume":"147","author":"Vianello","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101841_b0110","article-title":"Human intravenous immunoglobulins for recurrent pericarditis: A multicentre cohort study","volume":"28","author":"Collini","year":"2025","journal-title":"Eur J Prev. Cardiol."},{"issue":"25","key":"10.1016\/j.ijcha.2025.101841_b0115","first-page":"06503","article-title":"2025 Concise clinical guidance: An ACC expert consensus statement on the diagnosis and management of pericarditis: A report of the American college of cardiology solution set oversight committee","author":"Wang","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101841_b0120","unstructured":"Future Market Insights. Pericarditis Treatment Market \u2013 Global Market Analysis Report 2025\u20132035. London: Future Market Insights; 2025."},{"key":"10.1016\/j.ijcha.2025.101841_b0125","unstructured":"ARCALYST\u00ae (rilonacept) prescribing information. US FDA, Revised: 03\/2021. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/125249s049lbl.pdf."},{"issue":"8","key":"10.1016\/j.ijcha.2025.101841_b0130","first-page":"1494","article-title":"Canakinumab for recurrent rheumatic disease associated-pericarditis: A case series with long-term follow-up","volume":"57","author":"Kougkas","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijcha.2025.101841_b0135","unstructured":"Kiniksa Pharmaceuticals Ltd. Trial design of planned Phase2\/3 clinical trial of KPL-387 in recurrent pericarditis [press release]. Lexington (MA): Kiniksa Pharmaceuticals Ltd.; 2025 May29."},{"key":"10.1016\/j.ijcha.2025.101841_b0140","unstructured":"ClinicalTrials.gov: \u201cAn Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis,\u201d NCT06836232."},{"key":"10.1016\/j.ijcha.2025.101841_b0145","unstructured":"Cardiol Therapeutics Inc. CardiolRx Phase3 trial commencement in recurrent pericarditis [press release]. Oakville (ON): Cardiol Therapeutics Inc.; 2025 Apr16."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101841_b0150","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3109\/14397595.2013.874733","article-title":"Successful treatment with tocilizumab of pericarditis associated with rheumatoid arthritis","volume":"24","author":"Yoshida","year":"2014","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.ijcha.2025.101841_b0155","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-215423","article-title":"Successful treatment of recurrent pleural and pericardial effusions with tocilizumab in a patient with systemic lupus erythematous","author":"Ocampo","year":"2016","journal-title":"BMJ Case Rep."},{"issue":"11","key":"10.1016\/j.ijcha.2025.101841_b0160","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2459\/JCM.0000000000001669","article-title":"Genetic variants in patients with recurrent pericarditis","volume":"25","author":"Imazio","year":"2024","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"439","key":"10.1016\/j.ijcha.2025.101841_b0165","article-title":"Prognostic role of genetic variants in recurrent pericarditis","volume":"15","author":"Collini","year":"2025","journal-title":"Int. J. Cardiol."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725002441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725002441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T16:44:02Z","timestamp":1764866642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906725002441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"alternative-id":["S2352906725002441"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101841","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pericarditis at the crossroads: Unlocking the next wave of therapies","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101841"}}